These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 3050410
1. Naftifine for fungal skin infections. Med Lett Drugs Ther; 1988 Oct 21; 30(777):98-9. PubMed ID: 3050410 [No Abstract] [Full Text] [Related]
2. Naftifine cream in the treatment of cutaneous candidiasis. Zaias N, Astorga E, Cordero CN, Day RM, de Espinoza ZD, DeGryse R, Rojas RF, Sefton J. Cutis; 1988 Sep 21; 42(3):238-40. PubMed ID: 3048914 [Abstract] [Full Text] [Related]
7. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis. Gold M, Dhawan S, Verma A, Kuligowski M, Dobrowski D. J Drugs Dermatol; 2016 Jun 01; 15(6):743-8. PubMed ID: 27272083 [Abstract] [Full Text] [Related]
8. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor. Gold MH, Bridges T, Avakian E, Plaum S, Pappert EJ, Fleischer AB, Hardas B. Skinmed; 2011 Jun 01; 9(5):283-6. PubMed ID: 22165042 [Abstract] [Full Text] [Related]
9. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. Jordon RE, Rapini RP, Rex IH, Katz HI, Hickman JG, Bard JW, Medansky RS, Lew-Kaya DA, Sefton J, DeGryse RE. Int J Dermatol; 1990 Jun 01; 29(6):441-2. PubMed ID: 2397973 [Abstract] [Full Text] [Related]
11. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)]. Hantschke D, Reichenberger M. Mykosen; 1980 Dec 01; 23(12):657-68. PubMed ID: 7012610 [No Abstract] [Full Text] [Related]
12. Naftifine: a topical allylamine antifungal agent. Mühlbacher JM. Clin Dermatol; 1991 Dec 01; 9(4):479-85. PubMed ID: 1822408 [No Abstract] [Full Text] [Related]
13. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J. J Am Acad Dermatol; 1992 Jan 01; 26(1):125-7. PubMed ID: 1732321 [No Abstract] [Full Text] [Related]
14. Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea. Alghaith AF, Alshehri S, Alhakamy NA, Hosny KM. Drug Deliv; 2021 Dec 01; 28(1):343-356. PubMed ID: 33517791 [Abstract] [Full Text] [Related]
17. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia. Hira SK, Abraham MS, Mwinga A, Kamanga J, Schmidt C. Mykosen; 1986 Aug 01; 29(8):378-81. PubMed ID: 3531847 [No Abstract] [Full Text] [Related]
18. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine]. Albanese G, Giorgetti P, Santagostino L, Di Cintio R, Colombo MD. G Ital Dermatol Venereol; 1989 May 01; 124(5):XXXIII-XXXVII. PubMed ID: 2620916 [Abstract] [Full Text] [Related]
19. Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%. Plaum S, Verma A, Fleischer AB, Olayinka B, Hardas B. J Drugs Dermatol; 2013 Sep 01; 12(9):1004-8. PubMed ID: 24002147 [Abstract] [Full Text] [Related]
20. In vitro and in vivo cutaneous penetration and antifungal activity of naftifine. Stoughton RB, Sefton J, Zeleznick L. Cutis; 1989 Oct 01; 44(4):333-5. PubMed ID: 2805810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]